These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 18837128)
1. Intensive glucose control in type 2 diabetes. Parashar A N Engl J Med; 2008 Oct; 359(14):1520; author reply 1520-1. PubMed ID: 18837128 [No Abstract] [Full Text] [Related]
2. [Hypertension therapy for type 2 diabetics]. Bönner G MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579 [No Abstract] [Full Text] [Related]
3. Intensive glucose control in type 2 diabetes. Tobey TA N Engl J Med; 2008 Oct; 359(14):1520; author reply 1520-1. PubMed ID: 18837145 [No Abstract] [Full Text] [Related]
4. Vascular and renal benefits are additive using intensive blood pressure control and incremental glucose control in type 2 diabetic patients. Cardiovasc J Afr; 2008; 19(5):284-6. PubMed ID: 18997995 [No Abstract] [Full Text] [Related]
5. Does lowering of blood glucose improve cardiovascular morbidity and mortality? Iqbal N; Rubenstein AH Clin J Am Soc Nephrol; 2008 Jan; 3(1):163-7. PubMed ID: 18178783 [No Abstract] [Full Text] [Related]
6. ADVANCE trial of great importance in preventing cardiovascular deaths in type 2 diabetes. Cardiovasc J Afr; 2007; 18(5):343-4. PubMed ID: 17985038 [No Abstract] [Full Text] [Related]
7. Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus. Chaturvedi N; Bilous R; Sjolie AK; Klein R; Contemp Clin Trials; 2007 Nov; 28(6):780. PubMed ID: 17643353 [No Abstract] [Full Text] [Related]
8. Follow-up of intensive glucose control in type 2 diabetes. Mühlhauser I N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674 [No Abstract] [Full Text] [Related]
9. Follow-up of intensive glucose control in type 2 diabetes. Petrie JR N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672 [No Abstract] [Full Text] [Related]
10. Should patients with type 2 diabetes focus on glycemic control to reduce their cardiovascular risk? Montori VM Pol Arch Med Wewn; 2008 Sep; 118(9):502-7. PubMed ID: 18846985 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease and intensive glucose lowering in type 2 diabetes. Younis N; Soran H; Hassanein M QJM; 2009 Apr; 102(4):293-6. PubMed ID: 19147659 [No Abstract] [Full Text] [Related]
16. [Ambitious American guidelines for control of risk factors in diabetes. Was the aim put too high?]. Nilsson P; Attvall S; Weiss L Lakartidningen; 2003 Jan; 100(1-2):26-30. PubMed ID: 12572133 [No Abstract] [Full Text] [Related]
17. Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes. Sirois C; Moisan J; Poirier P; Grégoire JP Diabetes Care; 2007 Jul; 30(7):1880-2. PubMed ID: 17384345 [No Abstract] [Full Text] [Related]
18. [Evidence-based reduction of complications of type 2 diabetes following intensive antihypertensive treatment]. Hansen KW; Poulsen PL; Mogensen CE Ugeskr Laeger; 1999 Aug; 161(34):4764. PubMed ID: 10500468 [No Abstract] [Full Text] [Related]
19. [Optimal therapeutic strategy in type 2 diabetes mellitus]. Scherbaum WA; Nitschmann S Internist (Berl); 2009 Feb; 50(2):244-8. PubMed ID: 19183919 [No Abstract] [Full Text] [Related]
20. [The kidneys and diabetes]. Rüster C; Sämann A; Wolf G Dtsch Med Wochenschr; 2008 Sep; 133(37):1848-52. PubMed ID: 18770486 [No Abstract] [Full Text] [Related] [Next] [New Search]